Cite
HARVARD Citation
Kaehler, K. et al. (2016). Preferences of German melanoma patients for interferon (IFN) α-2b toxicities (the DeCOG "GERMELATOX survey") versus melanoma recurrence to quantify patients' relative values for adjuvant therapy. Medicine. 95 (46), pp. e5375-. [Online].